Ascentage Pharma Group International (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

18.86

-0.13 (-0.68%)

Aug 10, 2026, 4:00 PM EDT - Market closed

AAPG Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	574.12	574.12	980.65	221.98	209.71	27.91
Revenue Growth	46.98%	-41.45%	341.77%	5.85%	651.38%	124.18%
Gross Profit	525.18	525.18	951.57	191.44	187.71	24.58
Operating Income	-1,286	-1,286	-387.88	-897.2	-901.08	-983.57
Net Income	-1,243	-1,243	-405.43	-925.64	-882.92	-782.42
Earnings Per Share	-13.96	-13.96	-5.36	-13.12	-13.40	-12.28
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	574.12	574.12	302.24	221.98	209.71	14.97
Switzerland	-	-	678.42	-	-	-
Total	574.12	574.12	980.65	221.98	209.71	27.91

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,470	2,470	1,261	1,094	1,492	1,744
Total Debt	1,980	1,980	1,668	1,796	1,793	1,084
Net Cash (Debt)	490.37	490.37	-407.29	-701.76	-300.49	659.53
Net Cash Growth	-	-	-	-	-	33.32%
Net Cash Per Share	5.51	5.51	-5.39	-9.94	-4.56	10.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1,174	-1,174	-111.36	-726.08	-653.92	-600.83
Capital Expenditures	-27.57	-27.57	-24.29	-46.11	-203.29	-435.42
Free Cash Flow	-1,202	-1,202	-135.65	-772.19	-857.2	-1,036
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	91.48%	91.48%	97.03%	86.24%	89.51%	88.08%
Operating Margin	-223.96%	-223.96%	-39.55%	-404.17%	-429.68%	-3524.09%
Pretax Margin	-101.95%	-215.29%	-40.31%	-420.24%	-423.05%	-2981.90%
Profit Margin	-102.91%	-216.50%	-41.37%	-417.02%	-421.02%	-2803.38%
FCF Margin	-209.31%	-209.31%	-13.83%	-347.86%	-408.75%	-3712.82%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	20.76	29.84	-	-	-	-